Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.11.26.690714

Staphylococcus aureus urease is controlled by a complex regulatory network and promotes dissemination during catheter-associated urinary tract infections (CAUTI)

Abstract

Catheter-associated urinary tract infections (CAUTIs) are one of the most common hospital-associated infections in the United States, accounting for >1 million cases annually. One CAUTI-associated pathogen, Staphylococcus aureus, is commonly found persisting asymptomatically in the bladder of catheterized individuals, increasing these individuals risk of developing CAUTI. Importantly, S. aureus is not only associated with severe symptoms, including bacteremia and septic shock, but it also produces a common uropathogen associated virulence factor, urease. Despite its importance, urease has only been well-studied in the uropathogen Proteus mirabilis. While previous studies identified three S. aureus urease regulators, CodY, CcpA, and Agr, the environmental signals required for expression and activity, and the contribution of urease to CAUTI have not been explored. In this study, we investigate how the urease regulatory pathways coordinate expression and activity in response to environmental signals present within the catheterized urinary tract. Our findings demonstrate that stationary phase significantly induces S. aureus urease expression and activity. Additionally, we identified predicted binding sites in the urease promoter for three regulators previously implicated in urease expression - CodY, CcpA, and SigB - as well as SrrA - a previously unrecognized regulator of urease. A binding site for Agr was not present in the urease promoter. Expression and activity assays confirm the role of CodY, CcpA, SigB, SrrA, and Agr in regulating urease. Importantly, single nucleotide polymorphisms identified in the urease promoter of clinical isolates enhance urease expression. Additionally, urease promotes biofilm formation under catheterized urinary tract-like conditions in vitro and dissemination from the bladder to the kidneys at 1 day post infection in a mouse CAUTI model. Together, our data not only provide insight into the regulatory pathway controlling S. aureus urease but also emphasize the importance of studying these mechanisms in a model that mimics the host environment. AUTHOR SUMMARYCatheter-associated urinary tract infections (CAUTIs) are common hospital-associated infections and are caused by many different pathogens. Of these pathogens, Staphylococcus aureus is particularly problematic, as it often spreads to the bloodstream and results in septic shock. One of the primary virulence factors that is important for uropathogens is urease. Urease breaks down urea in urine, which results in crystalline structures that encrust urinary catheters and promote reflux to the kidney. Despite producing urease, little is known about how S. aureus regulates the enzyme. In this study, we investigate how regulatory pathways coordinate the expression and activity of urease in response to environmental signals. We show that growth during stationary phase and in conditions that mimic the urinary tract urease expression and activity are increased. We also show that five different regulators - CodY, CcpA, SigB, SrrA, and Agr control urease expression and activity. Additionally, genomic changes identified in the urease regulatory pathway of clinical urinary catheter-associated isolates enhance urease expression. Importantly, urease promotes biofilm formation and dissemination during CAUTI. Our study provides insight into the complex regulatory mechanisms controlling urease and highlights the role urease plays in the development and virulence of S. aureus CAUTI.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gomez, J., Duran-Ramirez, J., Alvarez, M., Cristy, S. A., Walker, J.. 2025-11-26. Staphylococcus aureus urease is controlled by a complex regulatory network and promotes dissemination during catheter-associated urinary tract infections (CAUTI). https://doi.org/10.1101/2025.11.26.690714

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗